EMA prednisone coverage for business development, investment, and market access teams
Earlier
High impact NewsJun 14, 2026
FDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC
FDA · prostate cancer · 6 min
Dr. Elena RossiHigh impact NewsJun 13, 2026
Truqap gains US approval in PTEN-deficient metastatic prostate cancer
FDA · prostate cancer · 6 min
Dr. Elena RossiPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- Press Releases 443 articles
- Oncology 443 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways